Back to top

Top Ranked Growth Stocks to Buy for October 16th

Read MoreHide Full Article

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, October 16th:

Huntsman Corporation (HUN - Free Report) : This chemical company, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings advancing 2.3% over the last 60 days.

Huntsman has a PEG ratio 1.85, compared with 1.90 for the industry. The company possesses a Growth Score of A.

Five Below, Inc. (FIVE - Free Report) : This specialty value retailer, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.8% over the last 60 days.

Five Below has a PEG ratio 1.17, compared with 1.27 for the industry. The company possesses a Growth Score of A.

Marathon Petroleum Corporation (MPC - Free Report) : This oil and petroleum company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings advancing 11.2% over the last 60 days.

Marathon Petroleum has a PEG ratio 1.62, compared with 3.51 for the industry. The company possesses a Growth Score of A.

Big Lots, Inc. (BIG - Free Report) : This non-traditional, discount retailer, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.7% over the last 60 days.

Big Lots has a PEG ratio 0.90, compared with 1.41 for the industry. The company possesses a Growth Score of A.

Big Lots, Inc. PEG Ratio (TTM)

Big Lots, Inc. peg-ratio-ttm | Big Lots, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Growth score and how it is calculated here.

5 Trades Could Profit "Big-League" from Trump Policies

If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.

Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure.

See these buy recommendations now >>



More from Zacks Zacks #1 Rank Additions

You May Like